Author Login IJIRT Partner Network (IPN) Login

A New Era in Pharmaceutical Law: Reviewing Recent Amendments and Developments

  • Unique Paper ID: 166454
  • Volume: 11
  • Issue: 2
  • PageNo: 1071-1075
  • Abstract:
  • This review paper, titled "A New Era in Pharmaceutical Law: Reviewing Recent Amendments and Developments," provides a comprehensive analysis of the latest changes and advancements in pharmaceutical jurisprudence. The pharmaceutical industry is highly regulated, with laws and regulations evolving to keep pace with scientific progress, public health needs, and technological innovations. This paper examines recent amendments in drug approval processes, updates in patent laws, and new regulations for digital health and e-pharmacies. It also explores developments in good manufacturing practices (GMP), pharmacovigilance, and drug safety. Additionally, the paper highlights regulatory pathways for biologics and biosimilars, changes in intellectual property rights (IPR), and efforts towards global harmonization of pharmaceutical regulations. By reviewing these recent legal changes and their implications, this paper aims to provide a valuable resource for professionals and scholars in the pharmaceutical field, fostering a deeper understanding of the dynamic legal environment shaping the industry.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 11
  • Issue: 2
  • PageNo: 1071-1075

A New Era in Pharmaceutical Law: Reviewing Recent Amendments and Developments

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry